Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 14, 2024 (Week 50)
Reporting Area Gonorrhea §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 4,288 12,470 475,904 581,767
New England 196 450 13,250 16,239
Connecticut 38 85 2,438 3,996
Maine 1 24 588 588
Massachusetts 122 219 8,338 9,473
New Hampshire - 23 479 558
Rhode Island 28 212 1,229 1,411
Vermont 7 10 178 213
Middle Atlantic 469 1,573 66,628 72,496
New Jersey - 236 8,940 9,786
New York (excluding New York City) 242 304 11,821 13,112
New York City - 758 28,852 31,487
Pennsylvania 227 416 17,015 18,111
East North Central 369 1,583 56,810 74,642
Illinois - 510 14,220 24,449
Indiana 44 217 7,978 9,577
Michigan 58 319 11,986 14,672
Ohio 205 400 16,303 19,179
Wisconsin 62 170 6,323 6,765
West North Central 302 648 27,112 32,992
Iowa 45 83 3,053 3,659
Kansas 25 90 2,931 4,084
Minnesota 33 182 6,826 7,475
Missouri 195 260 9,935 12,168
Nebraska - 64 1,910 2,216
North Dakota 4 25 732 1,121
South Dakota - 56 1,725 2,269
South Atlantic 1,018 4,683 126,241 145,552
Delaware - 40 1,336 1,507
District of Columbia 67 140 5,389 5,598
Florida - 2,716 38,442 45,119
Georgia 285 643 26,804 29,699
Maryland 187 304 10,538 12,291
North Carolina - 514 19,140 25,560
South Carolina 200 290 10,908 11,589
Virginia 274 328 13,041 13,259
West Virginia 5 27 643 930
East South Central 282 789 17,619 36,931
Alabama 180 230 8,455 11,268
Kentucky 67 223 4,616 5,711
Mississippi 35 294 4,548 7,073
Tennessee - 245 - 12,879
West South Central 263 1,534 64,341 77,457
Arkansas 37 146 4,836 5,764
Louisiana 100 254 10,070 12,833
Oklahoma 20 98 3,842 6,774
Texas 106 1,126 45,593 52,086
Mountain 261 695 29,539 35,070
Arizona 46 289 12,143 13,698
Colorado 115 189 5,968 7,258
Idaho 9 32 619 752
Montana 7 28 708 745
Nevada - 155 5,200 6,316
New Mexico 29 73 2,644 3,467
Utah 54 62 2,078 2,597
Wyoming 1 9 179 237
Pacific 1,128 1,850 74,364 90,388
Alaska 29 55 1,979 2,200
California 791 1,496 59,741 71,709
Hawaii - 34 - 1,778
Oregon 96 133 4,260 4,797
Washington 212 312 8,384 9,904
U.S. Territories - 29 37 1,145
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 29 37 1,145
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 2 16 25
Total 4,289 12,475 475,957 582,937
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, confirmed and probable cases only are being published to align with the approved CSTE position statement 22-ID-03, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.
Notes:
  • These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly in alphabetical order by condition. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Weekly tables since 1996 are available on CDC WONDER.
  • Weekly tables since 2014 are available on Data.CDC.gov.
  • Weekly tables for 1952–2017 published in the Morbidity and Mortality Weekly Reports (MMWR) are available at CDC Stacks MMWR, and weekly tables starting in 2018 are available at CDC Stacks NNDSS (once in CDC Stacks NNDSS select "Weekly Tables" in the "Genre" box at the left).
  • Notices, errata, and other notes are available in the Notice To Data Users page.
  • The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.
Suggested Citation:
  • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data. Atlanta, GA. Office of Public Health Data, Surveillance, and Technology. Available at: https://www.cdc.gov/nndss/data-statistics/index.html.
Acknowledgment:
  • CDC acknowledges the local, state, and territorial health departments that collected the data from a range of case ascertainment sources (e.g., health-care providers, hospitals, laboratories) and reported these data to CDC's National Notifiable Diseases Surveillance System.